Log In
Print
BCIQ
Print
Print this Print this
 

AndroGel 1.62%

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
Description1.62% testosterone gel
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism
Regulatory Designation

Partner

AbbVie Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today